Ivabradine Hydrochloridis Partis Chain CAS 85175-59-3 Purity >99.0% (HPLC) Factory
Ruifu Chemical Supple Ivabradine Hydrochloride media Cum High puritate
Ivabradine Hydrochloride CAS 148849-67-6
4,5-Dimethoxy-1-Cyanobenzocyclobutaneum CAS 35202-54-1
(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutaneum hydrochloridum CAS 866783-13-3
7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one CAS 73942-87-7
7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one CAS 148870-57-9
3-(3-Chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2(3H)-one CAS 85175-59-3
Nomen chemicum | 3-(3-Chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2(3H)-unum |
Synonyma | Ivabradine Hydrochloride Side Chain;(Z) -3-(3-Chloropropyl)-7,8-diethyl-1H-benzo[d]azepin-2(3H)-one;7,8-Dimethoxy-3-(3-chloropropyl)-1,3-dihydro-2H-3-benzazepin-2-unum |
CAS Number | 85175-59-3 |
CATTUS Number | RF-PI1807 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C15H18ClNO3 |
M. Pondus | 295.76 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Off-White vel Alba pulveris |
Lepidium sativum | HPC, NMR;LC-MS |
Puritas / Analysis Methodus | >99.0% (HPLC) |
Damnum in Siccatio | <0.50% (sicco ad 60℃ in vacuo usque ad constantem pondus) |
Residere in Ignition | <0.10% |
Substantiae cognatae | |
Individual Impurity | <0.50% |
Totalis immunditias | <1.00% |
Metalla gravis | <10ppm |
Test Standard | Enterprise Standard |
Consuetudinem | Intermedia Ivabradine Hydrochloridis (CAS: 148849-67-6) |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
3-(3-Chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2(3H) unum (CAS: 85175-59-3) est catena lateralis Hydrochloridis Ivabradini (CAS: 148849-67-6 ).Ivabradine et eius sales medicinales, praesertim eius hydrochloridi, magni ponderis proprietates pharmacologicas et therapeuticas habent, praesertim in tarditate cordis.Compositiones relativae adhiberi possunt ad varias condiciones ischemiae myocardiales clinicae tractandas vel prohibendas, sicut angina pectoris, infarctio myocardialis et perturbationes rhythmi affinis, variae pathologiae rhythmicae perturbationes, praesertim rhythmi supraventriculares perturbationes.